pictilisib (GDC-0941)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for pictilisib (GDC-0941), covering 2016-11-02 to 2017-06-27. Get the full timeline:
Most recent: Clinical Trial Update: GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast Cancer [Phase 1, Phase 2]